AP
Therapeutic Areas
Cabaletta Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| rese-cel (resecabtagene autoleucel) | Systemic Lupus Erythematosus (SLE) | Phase 1/2 |
Leadership Team at Cabaletta Bio
SN
Steven Nichtberger
President, Chief Executive Officer, and Co-Founder
SB
Samik Basu
Chief Scientific Officer
GB
Gwendolyn Binder
President, Science & Technology
CB
Catherine Bollard
Independent Director
SB
Scott Brun
Independent Director
MC
Michael C. Milone
Scientific Advisory Board Member
JS
Jay Siegel
Scientific Advisory Board Member